These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 10609463

  • 1. [New perspectives in the treatment of the motor complications associated with chronic treatment of Parkinson disease].
    Linazasoro G.
    Neurologia; 1999 Oct; 14(8):393-406. PubMed ID: 10609463
    [No Abstract] [Full Text] [Related]

  • 2. Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia.
    Stacy M, Galbreath A.
    Clin Neuropharmacol; 2008 Oct; 31(1):51-6. PubMed ID: 18303491
    [Abstract] [Full Text] [Related]

  • 3. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract] [Full Text] [Related]

  • 4. Other pharmacological treatments for motor complications and dyskinesias.
    Waters C.
    Mov Disord; 2005 Jan; 20 Suppl 11():S38-44. PubMed ID: 15822104
    [Abstract] [Full Text] [Related]

  • 5. [Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review].
    Bode M.
    Ugeskr Laeger; 2009 Oct 05; 171(41):2996-9. PubMed ID: 19814927
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of later phases of Parkinson disease].
    Tison F.
    Rev Neurol (Paris); 2008 Apr 05; 164 Spec No 2():F85-8. PubMed ID: 18680823
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of levodopa-induced motor complications.
    Stocchi F, Tagliati M, Olanow CW.
    Mov Disord; 2008 Apr 05; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [Abstract] [Full Text] [Related]

  • 8. The management approaches to dyskinesia vary from country to country.
    Woitalla D, Mueller T, Russ H, Hock K, Haeger DA.
    Neuroepidemiology; 2007 Apr 05; 29(3-4):163-9. PubMed ID: 18043000
    [Abstract] [Full Text] [Related]

  • 9. New drugs in the treatment of Parkinson's disease. An introduction.
    Bracco F.
    Adv Neurol; 1996 Apr 05; 69():513-7. PubMed ID: 8615173
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Parkinson's disease.
    Hely MA, Fung VS, Morris JG.
    J Clin Neurosci; 2000 Nov 05; 7(6):484-94. PubMed ID: 11029227
    [Abstract] [Full Text] [Related]

  • 11. [Pergolide: a useful agonist for the treatment of Parkinson disease].
    Bonnet AM, Houeto JL.
    Rev Neurol (Paris); 2002 Jul 05; 158(6-7):744-5. PubMed ID: 12486908
    [Abstract] [Full Text] [Related]

  • 12. Are there clinically significant differences between dopamine agonists.
    Stocchi F, Vacca L, Onofrj M.
    Adv Neurol; 2003 Jul 05; 91():259-66. PubMed ID: 12442684
    [No Abstract] [Full Text] [Related]

  • 13. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T.
    J Neurol; 2002 Sep 05; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [Abstract] [Full Text] [Related]

  • 14. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
    Benbir G, Ozekmekçi S, Apaydin H, Delil S, Erginöz E.
    Clin Neurol Neurosurg; 2006 Dec 05; 108(8):726-32. PubMed ID: 16564615
    [Abstract] [Full Text] [Related]

  • 15. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
    Encarnacion EV, Hauser RA.
    Eur Neurol; 2008 Dec 05; 60(2):57-66. PubMed ID: 18480609
    [Abstract] [Full Text] [Related]

  • 16. Dyskinesias assessment: from CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies.
    Widner H, Defer GL.
    Mov Disord; 1999 Dec 05; 14 Suppl 1():60-6. PubMed ID: 10493405
    [No Abstract] [Full Text] [Related]

  • 17. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO.
    MMW Fortschr Med; 2002 May 06; Suppl 2():37-43. PubMed ID: 12070848
    [Abstract] [Full Text] [Related]

  • 18. Should levodopa be used anymore?
    Zegers de Beyl D.
    Acta Neurol Belg; 2002 Dec 06; 102(4):163-6. PubMed ID: 12534242
    [Abstract] [Full Text] [Related]

  • 19. Parkinson's disease: diagnosis and treatment.
    Rao SS, Hofmann LA, Shakil A.
    Am Fam Physician; 2006 Dec 15; 74(12):2046-54. PubMed ID: 17186710
    [Abstract] [Full Text] [Related]

  • 20. [Fluctuations and dyskinesias as early L-dopa-induced motor complications in severe Parkinsonian's patients].
    Vaamonde J, Ibáñez R, Gudín M, Hernández A.
    Neurologia; 2003 Apr 15; 18(3):162-5. PubMed ID: 12677484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.